Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Orange Sunshine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Definium Highlights LSD Clinical Advances at Investor Day
    Definium Highlights LSD Clinical Advances at Investor Day

    22 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260422742468/en/Definium-Therapeutics-Highlights-DT120-ODT-Lysergide-Tartrate-Clinical-Advancements-and-Commercial-Strategy-at-Investor-and-Analyst-Day

    BUSINESSWIRE
    22 Apr 2026
    Share Share
    MindMed Has Productive End-Of-Phase 2 Meeting With FDA For MM120 In GAD
    MindMed Has Productive End-Of-Phase 2 Meeting With FDA For MM120 In GAD

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240620626324/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
    BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

    27 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/27/2523270/0/en/BetterLife-Files-Comprehensive-Patent-for-BETR-001-and-Other-LSD-Derivatives.html

    GLOBENEWSWIRE
    27 Sep 2022
    Share Share
    MindMed Shows Publication of Study Comparing Acute Effects of LSD and Psilocybin
    MindMed Shows Publication of Study Comparing Acute Effects of LSD and Psilocybin

    02 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mindmed-announces-publication-of-study-comparing-the-acute-effects-of-lysergic-acid-diethylamide-and-psilocybin-in-healthy-subjects-301493703.html

    PRNEWSWIRE
    02 Mar 2022
    Share Share
    BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity
    BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity

    15 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/15/2385232/0/en/BetterLife-Lead-Drug-BETR-001-Promotes-Structural-Neural-Plasticity-in-Preclinical-Model.html

    GLOBENEWSWIRE
    15 Feb 2022
    Share Share
    BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001
    BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

    20 Jan 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/betterlife-receives-fda-response-on-its-pre-ind-application-for-major-depressive-disorder-mdd-treatment-with-betr-001-1643725774.pdf

    PRESS RELEASE
    20 Jan 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.